Relcof C Interactions
There are 524 drugs known to interact with Relcof C (codeine/guaifenesin), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 125 are major, 396 are moderate, and 3 are minor.
- View all 524 medications that may interact with Relcof C
- View Relcof C alcohol/food interactions (1)
- View Relcof C disease interactions (16)
Most frequently checked interactions
View interaction reports for Relcof C (codeine / guaifenesin) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- alfuzosin
- Allegra (fexofenadine)
- allopurinol
- Ambien (zolpidem)
- amoxicillin
- aspirin
- Astelin (azelastine nasal)
- atorvastatin
- calcium citrate
- Celexa (citalopram)
- clindamycin topical
- cyclobenzaprine
- diclofenac topical
- dicyclomine
- doxycycline
- fenofibrate
- fluocinonide topical
- Gemtesa (vibegron)
- Imitrex (sumatriptan)
- ipratropium
- ketoconazole topical
- Klonopin (clonazepam)
- levofloxacin
- magnesium oxide
- metformin
- Metoprolol Succinate ER (metoprolol)
- MetroGel (metronidazole topical)
- montelukast
- Mucinex (guaifenesin)
Relcof C alcohol/food interactions
There is 1 alcohol/food interaction with Relcof C (codeine / guaifenesin).
Relcof C disease interactions
There are 16 disease interactions with Relcof C (codeine / guaifenesin) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Report options
QR code containing a link to this page
More about Relcof C (codeine / guaifenesin)
- Relcof C consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.